Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
International Journal of Cardiology. Cardiovascular Risk and Prevention|March 7, 2023
Secondary prevention and follow-up of patients with ACS and not-at-target LDL: An Italian real-world retro-prospective analysis by the inertia groupMaurizio Del Pinto, Francesco Amico, Natale Brunetti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 5, 2020
Impact of body mass index on clinical outcome among elderly patients with acute coronary syndrome treated with percutaneous coronary intervention: Insights from the ELDERLY ACS 2 trialGiuseppe De Luca, Monica Verdoia, Stefano Savonitto, et al.
The American Journal of Medicine|May 10, 2021
Association of Sex with Outcome in Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionRoberta De Rosa, Nuccia Morici, Giuseppe De Luca, et al.
The American Journal of Medicine|November 18, 2018
Outcomes of Elderly Patients with ST-Elevation or Non-ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionNuccia Morici, Stefano Savonitto, Luca A Ferri, et al.
International Journal of Cardiology|July 30, 2022
Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trialGiuseppe De Luca, Monica Verdoia, Nuccia Morici, et al.
Circulation|February 21, 2018
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous RevascularizationStefano Savonitto, Luca A Ferri, Luigi Piatti, et al.
European Heart Journal|June 1, 2021
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)Heerajnarain Bulluck, Valeria Paradies, Emanuele Barbato, et al.
JAMA|September 3, 2013
Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trialPhilippe Gabriel Steg, Shamir R Mehta, Charles V Pollack, et al.
Circulation|February 6, 2026
Natural History of Patients With Histologically Proven Acute Eosinophilic MyocarditisEnrico Ammirati, Matteo Palazzini, Jukka Lehtonen, et al.
Pageof 11